These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


290 related items for PubMed ID: 11882622

  • 21. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats.
    Kanno S, Wu YJ, Lee PC, Billiar TR, Ho C.
    Circulation; 2001 Aug 21; 104(8):945-50. PubMed ID: 11514384
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats.
    Toblli JE, Cao G, DeRosa G, Di Gennaro F, Forcada P.
    Am J Hypertens; 2004 Feb 21; 17(2):172-80. PubMed ID: 14751661
    [Abstract] [Full Text] [Related]

  • 23. Interactions among ACE, kinins and NO.
    Linz W, Wohlfart P, Schölkens BA, Malinski T, Wiemer G.
    Cardiovasc Res; 1999 Aug 15; 43(3):549-61. PubMed ID: 10690327
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
    Kobayashi N, Hara K, Watanabe S, Higashi T, Matsuoka H.
    Am J Hypertens; 2000 Feb 15; 13(2):199-207. PubMed ID: 10701821
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F, Hürlimann D, Lüscher TF.
    J Cardiovasc Pharmacol; 2001 Apr 15; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [Abstract] [Full Text] [Related]

  • 28. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT, Lüscher TF.
    Am Heart J; 1997 Aug 15; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [Abstract] [Full Text] [Related]

  • 29. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM, Gordon JF, Davidson AO, Clark JS, Hamilton CA, Morton JJ, Campbell AM, Reid JL, Dominiczak AF.
    J Hypertens; 1995 Feb 15; 13(2):211-8. PubMed ID: 7615951
    [Abstract] [Full Text] [Related]

  • 30. Cardiovascular dysfunction in hypercholesterolemia associated with enhanced formation of AT1-receptor and of eicosanoids.
    Schwemmer M, Sommer O, Koeckerbauer R, Bassenge E.
    J Cardiovasc Pharmacol Ther; 2000 Jan 15; 5(1):59-68. PubMed ID: 10687675
    [Abstract] [Full Text] [Related]

  • 31. Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
    Ito A, Egashira K, Narishige T, Muramatsu K, Takeshita A.
    Circ J; 2002 Sep 15; 66(9):811-5. PubMed ID: 12224817
    [Abstract] [Full Text] [Related]

  • 32. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
    Ito A, Egashira K, Narishige T, Muramatsu K, Takeshita A.
    Jpn Circ J; 2001 Sep 15; 65(9):775-8. PubMed ID: 11548874
    [Abstract] [Full Text] [Related]

  • 33. Comparison of nitric oxide production in response to carbachol between macrovascular and microvascular cardiac endothelial cells.
    Miyashita T, Takeishi Y, Takahashi H, Miyamoto T, Fujii S, Yoshimura T, Tomoike H, Kato S, Kubota I.
    Circ J; 2002 May 15; 66(5):511-5. PubMed ID: 12030350
    [Abstract] [Full Text] [Related]

  • 34. Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats.
    Bachetti T, Comini L, Pasini E, Cargnoni A, Curello S, Ferrari R.
    J Mol Cell Cardiol; 2001 Mar 15; 33(3):395-403. PubMed ID: 11181009
    [Abstract] [Full Text] [Related]

  • 35. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
    Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS.
    Kidney Int; 2002 Jan 15; 61(1):186-94. PubMed ID: 11786100
    [Abstract] [Full Text] [Related]

  • 36. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.
    Varin R, Mulder P, Tamion F, Richard V, Henry JP, Lallemand F, Lerebours G, Thuillez C.
    Circulation; 2000 Jul 18; 102(3):351-6. PubMed ID: 10899101
    [Abstract] [Full Text] [Related]

  • 37. Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats.
    Yazawa H, Miyachi M, Furukawa M, Takahashi K, Takatsu M, Tsuboi K, Ohtake M, Murase T, Hattori T, Kato Y, Murohara T, Nagata K.
    J Card Fail; 2011 Dec 18; 17(12):1041-50. PubMed ID: 22123369
    [Abstract] [Full Text] [Related]

  • 38. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.
    Bauersachs J, Heck M, Fraccarollo D, Hildemann SK, Ertl G, Wehling M, Christ M.
    J Am Coll Cardiol; 2002 Jan 16; 39(2):351-8. PubMed ID: 11788231
    [Abstract] [Full Text] [Related]

  • 39. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase.
    Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H, Drexler H.
    Circulation; 2001 Feb 13; 103(6):799-805. PubMed ID: 11171786
    [Abstract] [Full Text] [Related]

  • 40. Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptors.
    Dao VT, Medini S, Bisha M, Balz V, Suvorava T, Bas M, Kojda G.
    Biochem Pharmacol; 2016 Jul 15; 112():24-36. PubMed ID: 27235748
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.